David Guzo

Array ( [id] => 1517010 [patent_doc_number] => 06500644 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Method for in vivo production of a mutant library in cells' [patent_app_type] => B1 [patent_app_number] => 09/670798 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7917 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500644.pdf [firstpage_image] =>[orig_patent_app_number] => 09670798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527922 [patent_doc_number] => 06479281 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/670075 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 13740 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479281.pdf [firstpage_image] =>[orig_patent_app_number] => 09670075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414759 [patent_doc_number] => 06511847 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Recombinant p53 adenovirus methods and compositions' [patent_app_type] => B1 [patent_app_number] => 09/668532 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 14231 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511847.pdf [firstpage_image] =>[orig_patent_app_number] => 09668532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500102 [patent_doc_number] => 06485977 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems' [patent_app_type] => B1 [patent_app_number] => 09/660742 [patent_app_country] => US [patent_app_date] => 2000-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9636 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485977.pdf [firstpage_image] =>[orig_patent_app_number] => 09660742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1230430 [patent_doc_number] => 06692750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Alphavirus expression vector' [patent_app_type] => B1 [patent_app_number] => 09/657312 [patent_app_country] => US [patent_app_date] => 2000-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7852 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692750.pdf [firstpage_image] =>[orig_patent_app_number] => 09657312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4341962 [patent_doc_number] => 06284470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Kits for cell concentration and lysate clearance using paramagnetic particles' [patent_app_type] => 1 [patent_app_number] => 9/645133 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 13100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284470.pdf [firstpage_image] =>[orig_patent_app_number] => 645133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1166221 [patent_doc_number] => 06759570 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Promoter and regulator sequences Ha ds10 G1: a gene lea of sunflower expressed exclusively in seeds from the maturation phase' [patent_app_type] => B1 [patent_app_number] => 09/600848 [patent_app_country] => US [patent_app_date] => 2000-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10184 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759570.pdf [firstpage_image] =>[orig_patent_app_number] => 09600848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005227 [patent_doc_number] => 06905819 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-14 [patent_title] => 'Plasmid autonomously replicable in coryneform bacteria' [patent_app_type] => utility [patent_app_number] => 09/636458 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4108 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/905/06905819.pdf [firstpage_image] =>[orig_patent_app_number] => 09636458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323748 [patent_doc_number] => 06329181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Helper functions for recombinant vector production' [patent_app_type] => 1 [patent_app_number] => 9/633566 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 13300 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329181.pdf [firstpage_image] =>[orig_patent_app_number] => 633566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559316 [patent_doc_number] => 06436643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Process for site-directed integration of multiple copies of a gene in a mould' [patent_app_type] => B1 [patent_app_number] => 09/581941 [patent_app_country] => US [patent_app_date] => 2000-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10825 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436643.pdf [firstpage_image] =>[orig_patent_app_number] => 09581941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 563774 [patent_doc_number] => 07465541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-16 [patent_title] => 'Vitamin D3-responsive sequences located 5′-upstream of p27/kip 1 gene and methods of screening for pharmaceutical agents using the sequences' [patent_app_type] => utility [patent_app_number] => 10/181614 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13019 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465541.pdf [firstpage_image] =>[orig_patent_app_number] => 10181614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1354627 [patent_doc_number] => 06572863 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Constitutive expression of non-infectious HIV-like particles' [patent_app_type] => B1 [patent_app_number] => 09/555834 [patent_app_country] => US [patent_app_date] => 2000-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 6737 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/572/06572863.pdf [firstpage_image] =>[orig_patent_app_number] => 09555834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558464 [patent_doc_number] => 06436394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/614495 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 30623 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436394.pdf [firstpage_image] =>[orig_patent_app_number] => 09614495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1487419 [patent_doc_number] => 06428953 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Method and means for producing high titer, safe, recombinant lentivirus vectors' [patent_app_type] => B1 [patent_app_number] => 09/604013 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8485 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428953.pdf [firstpage_image] =>[orig_patent_app_number] => 09604013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406030 [patent_doc_number] => 06524572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Targeting recombinant virus with a bispecific fusion protein ligand in coupling with an antibody to cells for gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/604107 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 10864 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524572.pdf [firstpage_image] =>[orig_patent_app_number] => 09604107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417300 [patent_doc_number] => 06514757 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Nodavirus-like DNA expression vector and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/595346 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10389 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514757.pdf [firstpage_image] =>[orig_patent_app_number] => 09595346 [rel_patent_id] =>[rel_patent_doc_number] =>)